89Bio, Inc.(ETNB)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ETNB 89Bio, Inc.

盘后交易 12-23 16:52:01 EST

7.99

+0.05

+0.63%

盘后7.99

+0.000.00%

16:01 EST

最高8.10	最低7.77	成交量120.77万
今开7.99	昨收7.94	日振幅4.16%
总市值9.39亿	流通市值6.36亿	总股本1.18亿
成交额959.96万	换手率1.52%	流通股本7,963万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"ETNB","market":"US","secType":"STK","nameCN":"89Bio, Inc.","latestPrice":7.99,"timestamp":1734987599999,"preClose":7.94,"halted":0,"volume":1207747,"hourTrading":{"tag":"盘后","latestPrice":7.99,"preClose":7.99,"latestTime":"16:01 EST","volume":22625,"amount":180773.75,"timestamp":1734987667681},"delay":0,"floatShares":79628700,"shares":117582220,"eps":-3.012954,"marketStatus":"盘后交易","marketStatusCode":4,"change":0.05,"latestTime":"12-23 16:52:01 EST","open":7.99,"high":8.1,"low":7.77,"amount":9599556.6156725,"amplitude":0.041562,"askPrice":8.45,"askSize":16,"bidPrice":7.83,"bidSize":51,"shortable":3,"etf":0,"ttmEps":-3.012954,"exchange":"NASDAQ","tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1735002000000},"adr":0,"listingDate":1573448400000,"adjPreClose":7.94,"preHourTrading":{"tag":"盘前","latestPrice":7.94,"preClose":7.94,"latestTime":"09:28 EST","volume":500,"amount":3970,"timestamp":1734964080133},"postHourTrading":{"tag":"盘后","latestPrice":7.99,"preClose":7.99,"latestTime":"16:01 EST","volume":22625,"amount":180773.75,"timestamp":1734987667681},"volumeRatio":0.480738,"impliedVol":0.2479,"impliedVolPercentile":0.0837},"requestUrl":"/m/hq/s/ETNB","defaultTab":"news","newsList":[{"id":"2489142059","title":"89Bio, Inc.盘中异动 急速下跌5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2489142059","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489142059?lang=zh_cn&edition=full","pubTime":"2024-12-05 05:00","pubTimestamp":1733346017,"startTime":"0","endTime":"0","summary":"北京时间2024年12月05日05时00分，89Bio, Inc.股票出现波动，股价急速下挫5.04%。截至发稿，该股报8.29美元/股，成交量45.6699万股，换手率0.39%，振幅5.50%。89Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.80%。89Bio, Inc.公司简介：89bio Inc 是一家总部位于美国的临床阶段生物制药公司，专注于肝脏和心脏代谢疾病疗法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205050017971bb05d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205050017971bb05d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4585","ETNB"],"gpt_icon":0},{"id":"2488560860","title":"89Bio, Inc.盘中异动 股价大涨5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2488560860","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488560860?lang=zh_cn&edition=full","pubTime":"2024-12-02 23:27","pubTimestamp":1733153245,"startTime":"0","endTime":"0","summary":"北京时间2024年12月02日23时27分，89Bio, Inc.股票出现异动，股价急速上涨5.12%。截至发稿，该股报9.45美元/股，成交量5.9605万股，换手率0.05%，振幅5.12%。89Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.04%。89Bio, Inc.公司简介：89bio Inc 是一家总部位于美国的临床阶段生物制药公司，专注于肝脏和心脏代谢疾病疗法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241202232725a266b6ad&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241202232725a266b6ad&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4139","ETNB"],"gpt_icon":0},{"id":"2486026080","title":"89Bio, Inc.盘中异动 急速拉升5.94%报9.28美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486026080","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486026080?lang=zh_cn&edition=full","pubTime":"2024-11-25 22:33","pubTimestamp":1732545229,"startTime":"0","endTime":"0","summary":"北京时间2024年11月25日22时33分，89Bio, Inc.股票出现异动，股价急速上涨5.94%。截至发稿，该股报9.28美元/股，成交量4.4312万股，换手率0.04%，振幅2.34%。89Bio, Inc.股票所在的生物技术行业中，整体涨幅为1.06%。89Bio, Inc.公司简介：89bio Inc 是一家总部位于美国的临床阶段生物制药公司，专注于肝脏和心脏代谢疾病疗法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125223350971a85bb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125223350971a85bb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4585","ETNB"],"gpt_icon":0},{"id":"2483306251","title":"89Bio, Inc.2024财年第三财季实现净利润-1.49亿美元，同比减少329.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483306251","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483306251?lang=zh_cn&edition=full","pubTime":"2024-11-16 00:00","pubTimestamp":1731686434,"startTime":"0","endTime":"0","summary":"11月16日，89Bio, Inc.公布财报，公告显示公司2024财年第三财季净利润为-1.49亿美元，同比减少329.02%；其中营业收入为0.00美元，每股基本收益为-1.39美元。从资产负债表来看，89Bio, Inc.总负债80.20百万美元，其中短期债务743000.00美元，资产负债比为0.06，流动比率为0.12。机构评级：截至2024年11月16日，当前有7家机构对89Bio, Inc.目标价做出预测，其中目标均价为30.86美元，其中最低目标价为12.00美元，最高目标价为49.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241116000256a23b8989&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241116000256a23b8989&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ETNB"],"gpt_icon":0},{"id":"2483833213","title":"BUZZ--美国股票走势-BankUnited, Natera, Adaptimmune","url":"https://stock-news.laohu8.com/highlight/detail?id=2483833213","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483833213?lang=zh_cn&edition=full","pubTime":"2024-11-14 00:01","pubTimestamp":1731513684,"startTime":"0","endTime":"0","summary":"        *      Eikon 个股走势搜索字符串：[STXBZ］        *      The Day Ahead 新闻通讯：          *      The Morning News Call时事通讯：      11月13日 - 周三，华尔街主要股指走高，因消费者价格通胀数据符合预期，使美国联邦储备理事会有望在12月再次降息。美国东部时间10:31，道琼斯工业平均指数  上涨0.10%，报43956.01点；标普500指数  下跌0.08%，报5979.25点；纳斯达克综合指数  下跌0.25%，报19232.38点。** BTC Digital Ltd   ，上涨 63.7  纳斯达克  百分比跌幅前三名：** Syros Pharmaceuticals Inc   ，下跌 86.1% ** GlucoTrack Inc   ，下跌 74.4 ** Wag！","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DXD","DJX","RIVN","COTY","NTRA","SQQQ","LXEO","KNX","POAI","PAY","HON","SYRS","ODFL",".SPX","VVX","NQmain","MNQmain","BKU","SAIA","QID","DDM","DAVE","CTRA","SPOT","ALB","ETNB","GEV","DOG","CAT","GDYN","CART","HTLD",".DJI","CAVA","SDOW","SWKS","SAVE","BRTX","ADAP","AMGN","PSQ","SSYS","QLD","TQQQ",".IXIC"],"gpt_icon":1},{"id":"2483811438","title":"89Bio, Inc.盘中异动 股价大涨5.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483811438","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483811438?lang=zh_cn&edition=full","pubTime":"2024-11-13 22:32","pubTimestamp":1731508356,"startTime":"0","endTime":"0","summary":"北京时间2024年11月13日22时32分，89Bio, Inc.股票出现波动，股价快速拉升5.52%。截至发稿，该股报9.55美元/股，成交量38.8283万股，换手率0.37%，振幅5.30%。89Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.15%。89Bio, Inc.公司简介：89bio Inc 是一家总部位于美国的临床阶段生物制药公司，专注于肝脏和心脏代谢疾病疗法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113223236abbdde16&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113223236abbdde16&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ETNB","BK4585","BK4139"],"gpt_icon":0},{"id":"2483003004","title":"BUZZ-89bio 在 1.25 亿美元股票交易后下滑","url":"https://stock-news.laohu8.com/highlight/detail?id=2483003004","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483003004?lang=zh_cn&edition=full","pubTime":"2024-11-13 20:57","pubTimestamp":1731502621,"startTime":"0","endTime":"0","summary":"    11月13日 -    ** 89Bio   股价在隔夜后续定价后下跌 3.9%，盘前报 8.70 美元。** 肝病专家在周二晚些时候以 8.50 美元的价格出售了 () ~1470 万股股票，其中包括 325 万份预先筹资的认股权证，总收益为 1.25 亿美元。** 公司将在 11 月 15-19 日于圣地亚哥举行的第 75 届 \"肝脏会议 ()\"医疗保健会议上展示的 IIb 期试验数据。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4127","ETNB","BK4550","GRO","IE00B19Z3B42.SGD","BK4139","LU2237443895.HKD","IE00BSNM7G36.USD","IE0002270589.USD","BK4585","LU1668664300.SGD","LU2237443622.USD","IE0004086264.USD","BK4552","LU0106831901.USD","IE00BFXG1179.USD","BK4533","BK4516","LU2237443382.USD","LU2237443978.SGD","LU1791807156.HKD","LU2237443465.HKD","LU2237438978.USD","BK4504","LU2237443549.SGD","IE00B19Z3581.USD","IE0034235188.USD","IE0004091025.USD","BK4588"],"gpt_icon":1},{"id":"2481101180","title":"89Bio, Inc.盘中异动 股价大跌7.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481101180","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481101180?lang=zh_cn&edition=full","pubTime":"2024-11-08 22:35","pubTimestamp":1731076505,"startTime":"0","endTime":"0","summary":"北京时间2024年11月08日22时35分，89Bio, Inc.股票出现异动，股价急速下挫7.43%。截至发稿，该股报9.22美元/股，成交量2.3739万股，换手率0.02%，振幅4.02%。89Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.33%。89Bio, Inc.公司简介：89bio Inc 是一家总部位于美国的临床阶段生物制药公司，专注于肝脏和心脏代谢疾病疗法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108223505abae3e4a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108223505abae3e4a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4585","ETNB"],"gpt_icon":0},{"id":"2481981117","title":"89Bio, Inc.盘中异动 大幅拉升6.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481981117","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481981117?lang=zh_cn&edition=full","pubTime":"2024-11-06 22:31","pubTimestamp":1730903471,"startTime":"0","endTime":"0","summary":"北京时间2024年11月06日22时31分，89Bio, Inc.股票出现异动，股价快速拉升6.39%。截至发稿，该股报9.82美元/股，成交量2.8515万股，换手率0.03%，振幅0.00%。89Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.91%。89Bio, Inc.公司简介：89bio Inc 是一家总部位于美国的临床阶段生物制药公司，专注于肝脏和心脏代谢疾病疗法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110622311195bddaf0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110622311195bddaf0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","ETNB","BK4139"],"gpt_icon":0},{"id":"2481619225","title":"89Bio Inc    预计每股亏损 64 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2481619225","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481619225?lang=zh_cn&edition=full","pubTime":"2024-11-06 12:33","pubTimestamp":1730867637,"startTime":"0","endTime":"0","summary":"   * 89Bio Inc    预计在11月7日公布截至2024年9月30日的业绩(估计)，季度收入将有所增长。* 根据 LSEG 的数据，7 位分析师的平均预期显示，这家总部位于加利福尼亚州旧金山的公司预计将实现营收 53.571 万美元。* LSEG 的分析师平均预计 89Bio Inc 每股亏损 64 美分。* 华尔街对 89Bio Inc 的 12 个月目标价中位数为 29.50 美元，高于其最新收盘价 9.23 美元。11月6日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"89Bio Inc    预计每股亏损 64 美分 - 财报前瞻","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ETNB"],"gpt_icon":0},{"id":"2476449919","title":"89Bio, Inc.盘中异动 大幅拉升5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2476449919","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476449919?lang=zh_cn&edition=full","pubTime":"2024-10-17 01:00","pubTimestamp":1729098020,"startTime":"0","endTime":"0","summary":"北京时间2024年10月17日01时00分，89Bio, Inc.股票出现波动，股价急速上涨5.11%。截至发稿，该股报8.43美元/股，成交量25.1678万股，换手率0.24%，振幅4.99%。89Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.38%。89Bio, Inc.公司简介：89bio Inc 是一家总部位于美国的临床阶段生物制药公司，专注于肝脏和心脏代谢疾病疗法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241017010020ab6a9583&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241017010020ab6a9583&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4139","ETNB"],"gpt_icon":0},{"id":"2473793204","title":"89Bio, Inc.盘中异动 股价大涨5.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2473793204","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473793204?lang=zh_cn&edition=full","pubTime":"2024-10-08 22:34","pubTimestamp":1728398075,"startTime":"0","endTime":"0","summary":"北京时间2024年10月08日22时34分，89Bio, Inc.股票出现异动，股价急速拉升5.39%。截至发稿，该股报7.73美元/股，成交量8.5281万股，换手率0.08%，振幅5.18%。89Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.18%。89Bio, Inc.公司简介：89bio Inc 是一家总部位于美国的临床阶段生物制药公司，专注于肝脏和心脏代谢疾病疗法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100822343698e3b32b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100822343698e3b32b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4139","ETNB"],"gpt_icon":0},{"id":"2467775944","title":"89Bio, Inc.盘中异动 大幅拉升5.07%报8.50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2467775944","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2467775944?lang=zh_cn&edition=full","pubTime":"2024-09-13 21:49","pubTimestamp":1726235368,"startTime":"0","endTime":"0","summary":"北京时间2024年09月13日21时49分，89Bio, Inc.股票出现异动，股价急速上涨5.07%。截至发稿，该股报8.50美元/股，成交量2.5569万股，换手率0.02%，振幅3.46%。89Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.18%。89Bio, Inc.公司简介：89bio Inc 是一家总部位于美国的临床阶段生物制药公司，专注于肝脏和心脏代谢疾病疗法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409132149289719b4a3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409132149289719b4a3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ETNB","BK4139","BK4585"],"gpt_icon":0},{"id":"2462118314","title":"89Bio, Inc.盘中异动 股价大跌5.07%报8.85美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2462118314","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2462118314?lang=zh_cn&edition=full","pubTime":"2024-08-27 23:54","pubTimestamp":1724774069,"startTime":"0","endTime":"0","summary":"北京时间2024年08月27日23时54分，89Bio, Inc.股票出现异动，股价急速下跌5.07%。截至发稿，该股报8.85美元/股，成交量5.7571万股，换手率0.05%，振幅6.38%。89Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.08%。89Bio, Inc.公司简介：89bio Inc 是一家总部位于美国的临床阶段生物制药公司，专注于肝脏和心脏代谢疾病疗法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408272354309719a327&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408272354309719a327&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ETNB","BK4585"],"gpt_icon":0},{"id":"2462926306","title":"89Bio, Inc.盘中异动 股价大涨5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2462926306","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2462926306?lang=zh_cn&edition=full","pubTime":"2024-08-27 03:53","pubTimestamp":1724701985,"startTime":"0","endTime":"0","summary":"北京时间2024年08月27日03时53分，89Bio, Inc.股票出现异动，股价急速上涨5.03%。截至发稿，该股报9.30美元/股，成交量44.7058万股，换手率0.42%，振幅6.10%。89Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.42%。89Bio, Inc.公司简介：89bio Inc 是一家总部位于美国的临床阶段生物制药公司，专注于肝脏和心脏代谢疾病疗法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240827035306a1d670be&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240827035306a1d670be&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","ETNB","BK4139"],"gpt_icon":0},{"id":"2460241820","title":"89Bio, Inc.2024财年第二财季实现净利润-47.97百万美元，同比减少24.95%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460241820","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460241820?lang=zh_cn&edition=full","pubTime":"2024-08-17 00:00","pubTimestamp":1723824033,"startTime":"0","endTime":"0","summary":"8月17日，89Bio, Inc.公布财报，公告显示公司2024财年第二财季净利润为-47.97百万美元，同比减少24.95%；其中营业收入为0.00美元，每股基本收益为-0.48美元。从资产负债表来看，89Bio, Inc.总负债67.22百万美元，其中短期债务5.53百万美元，资产负债比为0.09，流动比率为0.14。机构评级：截至2024年8月17日，当前有8家机构对89Bio, Inc.目标价做出预测，其中目标均价为32.12美元，其中最低目标价为12.00美元，最高目标价为53.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408170005299f31b09d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408170005299f31b09d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ETNB"],"gpt_icon":0},{"id":"2459202484","title":"89Bio, Inc.盘中异动 早盘股价大涨5.95%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459202484","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459202484?lang=zh_cn&edition=full","pubTime":"2024-08-15 21:31","pubTimestamp":1723728679,"startTime":"0","endTime":"0","summary":"北京时间2024年08月15日21时31分，89Bio, Inc.股票出现异动，股价快速拉升5.95%。截至发稿，该股报8.10美元/股，成交量7900股，换手率0.01%，振幅2.18%。89Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.61%。89Bio, Inc.公司简介：89bio Inc 是一家总部位于美国的临床阶段生物制药公司，专注于肝脏和心脏代谢疾病疗法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815213119a1d4705f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815213119a1d4705f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4139","ETNB"],"gpt_icon":0},{"id":"2459484239","title":"89Bio, Inc.盘中异动 股价大跌5.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459484239","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459484239?lang=zh_cn&edition=full","pubTime":"2024-08-15 03:27","pubTimestamp":1723663667,"startTime":"0","endTime":"0","summary":"北京时间2024年08月15日03时27分，89Bio, Inc.股票出现异动，股价快速下挫5.24%。截至发稿，该股报7.60美元/股，成交量26.3202万股，换手率0.25%，振幅6.48%。89Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.05%。89Bio, Inc.公司简介：89bio Inc 是一家总部位于美国的临床阶段生物制药公司，专注于肝脏和心脏代谢疾病疗法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815032748aefec1c5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815032748aefec1c5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ETNB","BK4139","BK4585"],"gpt_icon":0},{"id":"2457079123","title":"雷蒙德詹姆斯公司：维持89bio(ETNB.US)评级，由强烈买入调整至强烈买入评级, 目标价由50.00美元调整至53.","url":"https://stock-news.laohu8.com/highlight/detail?id=2457079123","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457079123?lang=zh_cn&edition=full","pubTime":"2024-08-07 01:11","pubTimestamp":1722964263,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4585","BK4139","ETNB"],"gpt_icon":0},{"id":"1122070967","title":"异动解读 | 89Bio, Inc.股价大跌5.01% 公司无重大利好消息","url":"https://stock-news.laohu8.com/highlight/detail?id=1122070967","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1122070967?lang=zh_cn&edition=full","pubTime":"2024-08-06 23:28","pubTimestamp":1722958126,"startTime":"0","endTime":"0","summary":"8月6日,生物技术公司89Bio, Inc.盘中股价大跌5.01%,报收7.96美元。公司当日并未发布任何重大利好消息,导致股价出现大幅下跌。\n\n分析人士指出,89Bio, Inc.近期并无重大利好消息传出,公司主要产品pegozafermin目前仍处于临床试验阶段,距离上市还有一段时间。同时,公司最新财报显示净利润为-47.97百万美元,亏损加大可能也是导致股价下跌的一个原因。\n\n不过,机构分析师对该股持乐观态度,78%的分析师给予买入评级。公司在肝脏和心脏代谢疾病领域的产品线被看好,如果临床试验进展顺利,未来仍有较大的上涨空间。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ETNB"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.89bio.com","stockEarnings":[{"period":"1week","weight":0.0325},{"period":"1month","weight":-0.005},{"period":"3month","weight":-0.0305},{"period":"6month","weight":-0.0681},{"period":"1year","weight":-0.2593},{"period":"ytd","weight":-0.2892}],"compareEarnings":[{"period":"1week","weight":-0.0221},{"period":"1month","weight":0.0006},{"period":"3month","weight":0.0397},{"period":"6month","weight":0.0851},{"period":"1year","weight":0.2499},{"period":"ytd","weight":0.243}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"89bio, Inc.于2019年6月作为一家特拉华州公司成立，以经营2018年1月在以色列注册成立的89Bio有限公司的业务。该公司是一家临床阶段的生物制药公司，专注于治疗肝脏和心脏代谢疾病的创新疗法的开发和商业化。公司主导候选产品pegozafermin是一种专门设计的成纤维细胞生长因子的糖聚乙二醇化类似物，目前正在开发用于治疗非酒精性脂肪性肝炎和用于治疗严重的高甘油三酯血症。","yearOnYearQuotes":[{"month":1,"riseRate":0.2,"avgChangeRate":-0.179236},{"month":2,"riseRate":0.8,"avgChangeRate":0.131113},{"month":3,"riseRate":0.4,"avgChangeRate":-0.076134},{"month":4,"riseRate":0.4,"avgChangeRate":-0.12055},{"month":5,"riseRate":0.6,"avgChangeRate":0.054165},{"month":6,"riseRate":0.6,"avgChangeRate":-0.022743},{"month":7,"riseRate":0.6,"avgChangeRate":0.088741},{"month":8,"riseRate":1,"avgChangeRate":0.16496},{"month":9,"riseRate":0.4,"avgChangeRate":-0.059438},{"month":10,"riseRate":0.4,"avgChangeRate":-0.003798},{"month":11,"riseRate":0.6,"avgChangeRate":-0.000698},{"month":12,"riseRate":0.333333,"avgChangeRate":0.09936}],"exchange":"NASDAQ","name":"89Bio, Inc.","nameEN":"89Bio, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"89Bio, Inc.(ETNB)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供89Bio, Inc.(ETNB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"89Bio, Inc.,ETNB,89Bio, Inc.股票,89Bio, Inc.股票老虎,89Bio, Inc.股票老虎国际,89Bio, Inc.行情,89Bio, Inc.股票行情,89Bio, Inc.股价,89Bio, Inc.股市,89Bio, Inc.股票价格,89Bio, Inc.股票交易,89Bio, Inc.股票购买,89Bio, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"89Bio, Inc.(ETNB)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供89Bio, Inc.(ETNB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}